GSK, Vir Biotech to test COVID-19 antibody treatment
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.